Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | PF-07104091 |
Trade Name | |
Synonyms | PF 07104091|PF07104091 |
Drug Descriptions |
PF-07104091 inhibits CDK2, which may result in cell cycle arrest, induction of apoptosis, and inhibition of tumor cell proliferation (NCI Drug Dictionary). |
DrugClasses | CDK2 Inhibitor 31 |
CAS Registry Number | 2460249-19-6 |
NCIT ID | C175251 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Fulvestrant + PF-07104091 + PF-07220060 | Fulvestrant PF-07104091 PF-07220060 | 0 | 1 |
Letrozole + Palbociclib + PF-07104091 | Letrozole PF-07104091 Palbociclib | 0 | 1 |
Letrozole + PF-07104091 + PF-07220060 | Letrozole PF-07104091 PF-07220060 | 0 | 1 |
Palbociclib + PF-07104091 | PF-07104091 Palbociclib | 0 | 1 |
PF-07104091 | PF-07104091 | 0 | 1 |
PF-07104091 + PF-07220060 | PF-07104091 PF-07220060 | 0 | 1 |